Methylation Status of hMLH1 Gene in Colorectal Cancer Patients in Ethnic Population of Kashmir Valley

Authors

  • Mashooq A Dar Department of Clinical Biochemistry, University Of Kashmir, Srinagar, India
  • Showkat A Bhat Faculty of Veterinary Sciences & Animal Husbandry Sher-e-Kashmir, University of Agricultural Sciences & Technology, Srinagar, India
  • Ahmad Arif Faculty of Veterinary Sciences & Animal Husbandry Sher-e-Kashmir, University of Agricultural Sciences & Technology, Srinagar, India
  • Hilal Ahmad Wani Department of Biochemistry, Govt. Medical College, Srinagar, India
  • Khalid B Dar Department of Clinical Biochemistry, University Of Kashmir, Srinagar, India
  • Rouf Maqbool Department of Clinical Biochemistry, University Of Kashmir, Srinagar, India
  • Suhail Anees Department of Clinical Biochemistry, University Of Kashmir, Srinagar, India
  • Manzoor R Mir Faculty of Veterinary Sciences & Animal Husbandry Sher-e-Kashmir, University of Agricultural Sciences & Technology, Srinagar, India

Keywords:

Colorectal cancer, hypermethylation, CpG islands, hMLH1 gene

Abstract

Background: Colorectal cancer is commonly known as bowel cancer, its development and progression is dictated by chain of alterations in genes such as tumor suppressor genes, DNA repair genes, oncogenes and others.

Method: The present work was a case control study aiming to ascertain the role of promoter methylation of CpG islands of hMLH1 gene in colorectal cancer patients among the Kashmiri population. DNA was extracted from all the samples and was modified using bisulphite modification kit. Methylation-specific polymerase chain reaction was used for the analysis of the promoter methylation status of hMLH1 gene.

Results: The epigenetic analysis revealed that unlike other high risk regions, Kashmiri population has a different promoter methylation profile of hMLH1 gene as 67.5 % of the cases showed hMLH1 promoter methylation in comparison to 15 % of the normal cases which also showed promoter methylation of hMLH1 gene. The association of promoter methylation with colorectal cancer was found to be significant (P=0.0006). Occurrence of hMLH1 promoter  methylation was found to be unequally distributed in males and females with more frequency in males than in females but the difference was not statistically significant (P=0.7635). Similarly, frequency of hMLH1 promoter methylation was found to be certainly higher in Stage III/IV (85.71%) compared to Stage I/ II (57.69%) but the difference was not statistically significant (P=0.0673).

Conclusion: The results suggest that hMLH1 aberrant promoter methylation in Kashmiri population contributes to the process of carcinogenesis in colorectal cancer and is reportedly one of the commonest epigenetic changes in the development of colorectal cancer.

References

1. Greenlee RT, Murray T, Bolden S and Wingo PA (2000): Cancer statistics, CA Cancer J Clin , 50:7-33, 2000.

2. Risques RA, Moreno V, Rias M, Marcuello E, Capella G, Peinado MA. Genetic pathways and genome wide deter-minants of clinical outcome in colorectal cancer. Cancer Res, 63:7206-14, 2003.

3. Cross SH, Bird AP: CpG islands and genes. CurrOpin Genet Dev 5:309-314, 1995

4. Costello JF &Plass C: Methylation matters. J Med Genet 38:285-303, 2001.

5. Fremont M, Siegmann M, Gaulis S, et al: Demethylation of DNA by purified chick embryo 5-methylcytosine-DNA glycosylase requires both protein and RNA. Nucleic Acids Res 25:2375-2380, 1997.

6. Helmtrud I. Roach, ‎Felix Bronner, ‎Richard O.C. Oreffo: Epigenetic Aspects of Chronic Diseases. books.google.co.in/ books?isbn=1848826443- 2011.

7. VJ Mutskov: The barrier function of an insulator couples high histone acetylation. genesdev.cshlp.org/content /16/12/1540.long‎ - ‎2002.

8. Greenlee RT, Murray T, Bolden S and Wingo PA, Cancer statistics. CA Cancer J Clin, 2000; 50: 7-33.

9. Alberto Morán, Paloma Ortega, Carmen de Juan, et al;Differential colorectal carcinogenesis: Molecular basis and clinical relevance World J Gastrointest Oncol 2010 March 15; 2(3): 151-158 ISSN 1948-5204. 2010.

10. Kinzler, Kenneth W, Vogelstein, Bert, "Introduction" The genetic basis of human cancer (2nd, illustrated, revised ed.). New York: McGraw-Hill, Medical Pub. Division 2002; p. 5.

11. Risques RA, Moreno V, Rias M, Marcuello E, Capella G, Peinado MA, Genetic pathways and genome wide deter-minants of clinical outcome in colorectal cancer. Cancer Res, 2003; 63:7206-14.

12. Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y, Colorectal cancer: genetics of development and metasta-sis. J Gastroenterol, 2006; 41:185-92.

13. Arif A. Bhat, Hila A. Wani, Mushtaq A. Beigh, Showkat A. Bhat: Epigenetic promoter methylation of hmlh1 gene in human gut malignancies: A comparative study. Journal of Investigational Biochemistry, 2013.

14. H.A.Wani, A.A.Bhat, A.A. Mattoo, et al: Distribution of P16 Promoter Hypermethylation in Male/Female Colo-rectal Cancer Patients of Kashmir Valley. International Journal of Engineering Science Invention, Volume 2 Issue 1 ǁ January. 2013 / PP.11-17.

15. Jones PA, Baylin SB, The fundamental role of epigenetic events in cancer. Nat Rev Genet, 2002; 3:415–28.

16. Kelly WK, O'Connor OA, Marks PA, Histone deacetylase inhibitors: from target to clinical trials. Expert Opion In-vestig Drugs, 2002; 11:1695–1713.

17. Baylin SB, Herman JG, DNA hypermethylation in tumor-igenesis: epigenetics joins genetics. Trends Genet, 2000; 16:168–74.

18. Herman JG, Jen J, Merlo A & Baylin SB, Cancer Res, 1996; 56: 722-727.

19. Herman JG, Baylin SB, Gene silencing in cancer in asso-ciation with promoter hypermethylation. N Engl J Med, 2003; 349:2042–54.

20. Jones PA, Laird PW: Cancer epigenetics comes of age. Nat Genet 21:163-167, 1999.

21. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428, 2002.

Downloads

Published

2013-10-01

How to Cite

Dar, M. A., Bhat, S. A., Ahmad Arif, Hilal Ahmad Wani, Khalid B Dar, Maqbool, R., … Manzoor R Mir. (2013). Methylation Status of hMLH1 Gene in Colorectal Cancer Patients in Ethnic Population of Kashmir Valley. International Journal of Medical Research, 1(04), 1–6. Retrieved from https://ijmrinternational.in/index.php/ijmr/article/view/26

Issue

Vol. 1 No. 04 (2013)

Section

Original Research Articles

License

The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.